Product Update Applied Medical Technology Ltd Insuflon™ Subcutaneous Catheter FSB081 (ICN 3041)

• The discontinuation with Insuflon™ Subcutaneous Catheter products from Applied Medical Technology Ltd is now resolved.
• FSB081 is in the process of being delisted and is no longer available to order through our online catalogue.
• This ICN is now closed.

• The discontinuation with Insuflon™ Subcutaneous Catheter products from Applied Medical Technology Ltd is continuing.
• FSB081 remains available whilst our stock lasts, once the stock is depleted the product code will be delisted.
• The potential alternative product codes have been amended and updated to include FSB1826 on the product listing.
• The online catalogue is in the process of being updated to reflect the updated product listing.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.

Change:

• The supplier Applied Medical Technology Ltd has informed us of a discontinuation with its Insuflon™ Subcutaneous Catheter products.
• One product code is affected:
• • FSB081 – Subcutaneous Catheter Insuflon Angled Insertion for use with Insulin.
• The supplier is discontinuing this product due to increased medical device regulatory costs.

Impact:          

• The affected product code is available whilst stocks last, it will then be delisted from our online catalogue.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing below for further information on the affected product code and potential alternatives.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• Once an alternative is chosen, please inform your ICS Manager to help us track increased demand.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.